创建者
Decisive Consulting Ltd
刊期
MHRA’s 2024/25 business plan offers exciting opportunities for innovative…
Decisive Consulting Ltd,发布于领英
Preparing for Joint Clinical Assessment: The increased importance of Indirect…
Decisive Consulting Ltd,发布于领英
Navigating Health Technology Assessment in an Era of Personalised Medicine
Decisive Consulting Ltd,发布于领英
更多文章
Is it Prime Time for ProBNP to unlock value? Measuring effectiveness in Heart Failure
2 个月
Innovative Medicines Fund Update
3 个月
Joint Nordic HTA Bodies (JNHB): further collaborations for HTA in Europe
4 个月